Home/Filings/4/A/0001628280-25-052350
4/A//SEC Filing

Juvenal Tobin W 4/A

Accession 0001628280-25-052350

CIK 0001447362other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:09 PM ET

Size

15.4 KB

Accession

0001628280-25-052350

Insider Transaction Report

Form 4/AAmended
Period: 2025-11-11
Juvenal Tobin W
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2025-11-11$35.39/sh500$17,69584,527 total
  • Exercise/Conversion

    Common Stock

    2025-11-11$3.38/sh+500$1,69085,027 total
  • Exercise/Conversion

    Common Stock

    2025-11-12$3.38/sh+200$67684,727 total
  • Sale

    Common Stock

    2025-11-12$35.40/sh200$7,08084,527 total
  • Exercise/Conversion

    Stock option (right to buy)

    2025-11-1150016,103 total
    Exercise: $3.38Exp: 2029-03-12Common Stock (500 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2025-11-1220015,903 total
    Exercise: $3.38Exp: 2029-03-12Common Stock (200 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    2,230
Footnotes (6)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 11, 2024.
  • [F2]This transaction was executed in multiple trades at prices ranging from $35.38 to $35.40, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed at a price of $35.40. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.
  • [F5]The exercise of the options was inadvertently omitted from the original Form 4 filing and is now being reported in this Amendment.
  • [F6]The shares subject to the option are fully vested.

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

Entity typeother

Related Parties

1
  • filerCIK 0001856542

Filing Metadata

Form type
4/A
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:09 PM ET
Size
15.4 KB